cytarabine and Keratoconjunctivitis

cytarabine has been researched along with Keratoconjunctivitis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ioannidis, AS; Samarawickrama, C; Watson, SL; Wechsler, AW1
Jenkins, A; Kell, J; Lane, C; Patel, AK; Sheehan, W1
Aisa, Y; Ichimura, M; Kato, J; Kawata, Y; Mori, T; Ogawa, Y; Okamoto, S; Shigematsu, N; Shimizu, T; Tsubota, K; Tsuneyama, C; Yamane, A; Yashima, T1
Aisa, Y; Ikeda, Y; Ito, C; Kato, J; Kobayashi, N; Kondo, S; Kubo, A; Kurotori-Sotome, T; Mori, T; Ogawa, Y; Okamoto, S; Shigematsu, N; Tsubota, K; Watanabe, M; Yamada, K; Yashima, T1
Gococo, KO; Lass, JH; Lazarus, HM1
Barletta, JP; Fanous, MM; Margo, CE1

Trials

2 trial(s) available for cytarabine and Keratoconjunctivitis

ArticleYear
Prophylactic treatment for cytosine arabinoside-induced keratoconjunctivitis.
    International ophthalmology, 2011, Volume: 31, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cytarabine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Leukemia, Myeloid, Acute; Male; Middle Aged; Ophthalmic Solutions; Prednisolone; Treatment Outcome; Young Adult

2011
The use of prophylactic eye drops during high-dose cytosine arabinoside therapy.
    Cancer, 1992, Jun-01, Volume: 69, Issue:11

    Topics: Administration, Topical; Cytarabine; Deoxycytidine; Double-Blind Method; Humans; Keratoconjunctivitis; Ophthalmic Solutions; Prednisolone; Prospective Studies

1992

Other Studies

4 other study(ies) available for cytarabine and Keratoconjunctivitis

ArticleYear
Bilateral corneal infections associated with topical steroid therapy prophylaxis for cytarabine arabinoside-induced keratoconjunctivitis.
    Leukemia, 2014, Volume: 28, Issue:1

    Topics: Administration, Topical; Adrenal Cortex Hormones; Cytarabine; Female; Humans; Keratoconjunctivitis; Middle Aged

2014
Prevention of cytarabine-induced kerato-conjunctivitis by eye rinse in patients receiving high-dose cytarabine and total body irradiation as a conditioning for hematopoietic stem cell transplantation.
    International journal of hematology, 2011, Volume: 94, Issue:3

    Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Keratoconjunctivitis; Male; Middle Aged; Severity of Illness Index; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation; Young Adult

2011
Reduced efficacy of topical corticosteroid in preventing cytarabine-induced kerato-conjunctivitis in patients receiving high-dose cytarabine and total body irradiation for allogeneic hematopoietic stem cell transplantation.
    Bone marrow transplantation, 2008, Volume: 42, Issue:3

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Keratoconjunctivitis; Leukemia; Male; Middle Aged; Myelodysplastic Syndromes; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation

2008
Corneal and conjunctival toxicity with low-dose cytosine arabinoside.
    American journal of ophthalmology, 1992, May-15, Volume: 113, Issue:5

    Topics: Conjunctiva; Cornea; Cytarabine; Dexamethasone; Humans; Keratoconjunctivitis; Leukemia, Myeloid, Acute; Male; Middle Aged; Visual Acuity

1992